1,065
Views
10
CrossRef citations to date
0
Altmetric
Editorial

Lipoxin A4: a new direction in asthma therapy?

&
Pages 491-493 | Published online: 10 Jan 2014
 

Acknowledgements

The work has been funded in part by AI068084 (BD Levy), HL107166 (BD Levy), HL109172 (BD Levy) and Fonds de dotation ‘Recherche en Santé Respiratoire’ 2011 (C Barnig).

Financial & competing interests disclosure

BD Levy is a co-inventor on patents related to lipoxin A4 and asthma that have been licensed by the Brigham and Women’s Hospital for clinical development, and receives a share of licensing income through Brigham and Women’s Hospital. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

No writing assistance was utilized in the production of this manuscript.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.